Annotation inferences using phylogenetic trees

Electronic Gene Ontology annotations created by ARBA machine learning models

Characterization of recombinant amino-terminal NC4 domain of human collagen IX: interaction with glycosaminoglycans and cartilage oligomeric matrix protein.

Crystal structure of the N-terminal NC4 domain of collagen IX, a zinc binding member of the laminin-neurexin-sex hormone binding globulin (LNS) domain family.

Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.

Structural insight for chain selection and stagger control in collagen.

Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains.

Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.

Structure of the glycosaminoglycan domain in the type IX collagen-proteoglycan.

Collagen type IX from human cartilage: a structural profile of intermolecular cross-linking sites.

Human COL9A1 and COL9A2 genes. Two genes of 90 and 15 kb code for similar polypeptides of the same collagen molecule.

Procollagen triple helix formation

Secretion of collagens

Collagen IX is cross-linked to the surface of collagen type II fibrils

Collagen types III, IV, V, VI, VIII, IX, XVI bind integrins alpha1beta1 and alpha2beta1

Interaction of NCAM1 with collagens

PDGF binds to extracellular matrix proteins

Collagen types VI, IX bind integrin alpha10beta1

Collagen type IX binds integrin alpha11beta1

Association of procollagen type IX

Trimerization of collagen IX alpha-chains does not require the presence of the COL1 and NC1 domains.

NC4 Domain of cartilage-specific collagen IX inhibits complement directly due to attenuation of membrane attack formation and indirectly through binding and enhancing activity of complement inhibitors C4B-binding protein and factor H.

The tyrosine sulfate-rich domains of the LRR proteins fibromodulin and osteoadherin bind motifs of basic clusters in a variety of heparin-binding proteins, including bioactive factors.